T. Yoneya

Identification of a novel, orally bioavailable estrogen receptor downregulator

H. Yamada-Okabe, K. Taniguchi, T. Tsunenari, 2005, Anti-cancer drugs.

A novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle model

Y. Sugimoto, A. Harada, H. Kawata, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Thiochroman derivative CH4986399, a new nonsteroidal estrogen receptor down-regulator, is effective in breast cancer models.

R. Nakamura, K. Taniguchi, S. Kaiho, 2010, Anticancer research.

Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.

Mee‐Hyun Lee, K. Taniguchi, T. Tsunenari, 2009, Oncology reports.

Newly discovered orally active pure antiestrogens.

Y. Nabuchi, Hyun‐Suk Lim, K. Taniguchi, 2006, Bioorganic & medicinal chemistry letters.